Abstract:Monoterpene indole alkaloids (MIAs) are a class of natural products comprised of thousands of structurally unique bioactive compounds with significant therapeutic values. Due to difficulties associated with isolation from native plant species and organic synthesis of these structurally complex molecules, microbial production of MIAs using engineered hosts are highly desired. In this work, we report the engineering of fully integrated Saccharomyces cerevisiae strains that allow de novo access to strictosidine, the universal precursor to thousands of MIAs at 30-40 mg/L. The optimization efforts were based on a previously reported yeast strain that is engineered to produce high titers of the monoterpene precursor geraniol through compartmentalization of mevalonate pathway in the mitochondria. Our approaches here included the use of CRISPR-dCas9 interference to identify mitochondria diphosphate transporters that negatively impact the titer of the monoterpene, followed by genetic inactivation; the overexpression of transcriptional regulators that increase cellular respiration and mitochondria biogenesis. Strain construction included the strategic integration of genes encoding both MIA biosynthetic and accessory enzymes into the genome under a variety of constitutive and inducible promoters. Following successful de novo production of strictosidine, complex alkaloids belonging to heteroyohimbine and corynantheine families were reconstituted in the host with introduction of additional downstream enzymes. We demonstrate that the serpentine/alstonine pair can be produced at ∼5 mg/L titer, while corynantheidine, the precursor to mitragynine can be produced at ∼1 mg/L titer. Feeding of halogenated tryptamine led to the biosynthesis of analogs of alkaloids in both families. Collectively, our yeast strain represents an excellent starting point to further engineer biosynthetic bottlenecks in this pathway and to access additional MIAs and analogs through microbial fermentation. One sentence summary: An Saccharomyces cerevisiae-based microbial platform was developed for the biosynthesis of monoterpene indole alkaloids, including the universal precursor strictosidine and further modified heteroyohimbine and corynantheidine alkaloids.

De novo production of protoberberine and benzophenanthridine alkaloids through metabolic engineering of yeast

Advancements in Microbial Cell Engineering for Benzylisoquinoline Alkaloid Production

Effects of codon optimization, N-terminal truncation and gene dose on the heterologous expression of berberine bridge enzyme

Complete biosynthesis of noscapine and halogenated alkaloids in yeast

Engineered biosynthesis of plant heteroyohimbine and corynantheine alkaloids in Saccharomyces cerevisiae

Metabolic Engineering Strategies for De Novo Biosynthesis of Sterols and Steroids in Yeast.

Microbial production of plant benzylisoquinoline alkaloids

Back to the plant: overcoming roadblocks to the microbial production of pharmaceutically important plant natural products

Construction of ajmalicine and sanguinarine de novo biosynthetic pathways using stable integration sites in yeast

Integrated pathway mining and selection of an artificial CYP79-mediated bypass to improve benzylisoquinoline alkaloid biosynthesis

Microbial Factories for the Production of Benzylisoquinoline Alkaloids

Engineering Saccharomyces cerevisiae for enhanced (–)-α-bisabolol production

De novo biosynthesis of betulinic acid in engineered Saccharomyces cerevisiae

De Novo Synthesis of 1-Phenethylisoquinoline in Engineered Escherichia Coli

Enhancement of β-Alanine Biosynthesis in Escherichia coli Based on Multivariate Modular Metabolic Engineering

De novo biosynthesis of bioactive isoflavonoids by engineered yeast cell factories

A yeast platform for high-level synthesis of natural and unnatural tetrahydroisoquinoline alkaloids

Multilevel metabolic engineering of Bacillus licheniformis for de novo biosynthesis of 2-phenylethanol

A yeast platform for high-level synthesis of tetrahydroisoquinoline alkaloids

Metabolic Engineering of Candida tropicalis for the De Novo Synthesis of β-Ionone

A tripartite microbial co-culture system for de novo biosynthesis of diverse plant phenylpropanoids